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Abstract: Human neutrophil elastase (HNE) is a uniquely destructive serine protease with the
ability to unleash a wave of proteolytic activity by destroying the inhibitors of other proteases.
Although this phenomenon forms an important part of the innate immune response to invading
pathogens, it is responsible for the collateral host tissue damage observed in chronic conditions
such as chronic obstructive pulmonary disease (COPD), and in more acute disorders such as the
lung injuries associated with COVID-19 infection. Previously, a combinatorially selected activitybased probe revealed an unexpected substrate preference for oxidised methionine, which suggests
a link to oxidative pathogen clearance by neutrophils. Here we use oxidised model substrates and
inhibitors to confirm this observation and to show that neutrophil elastase is specifically selective for
the di-oxygenated methionine sulfone rather than the mono-oxygenated methionine sulfoxide. We
also posit a critical role for ordered solvent in the mechanism of HNE discrimination between the
two oxidised forms methionine residue. Preference for the sulfone form of oxidised methionine is
especially significant. While both host and pathogens have the ability to reduce methionine sulfoxide
back to methionine, a biological pathway to reduce methionine sulfone is not known. Taken together,
these data suggest that the oxidative activity of neutrophils may create rapidly cleaved elastase
“super substrates” that directly damage tissue, while initiating a cycle of neutrophil oxidation that
increases elastase tissue damage and further neutrophil recruitment.
Keywords: human neutrophil elastase; peptide aldehyde; substrate guided inhibitor design; methionine oxidation; methionine sulfone; substrate selectivity

published maps and institutional affiliations.

1. Introduction
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Neutrophils of the human innate immune system use an armamentarium of chemical and enzymatic weapons to defend against pathogen invasion. Once triggered by
pathogens, neutrophils respond with a shower of powerful oxidising agents including
H2 O2 [1]; superoxide [2]; hypochlorous and hypobromous acids [3] (through the action
of myeloperoxidase) and release powerful proteolytic and lipolytic enzymes. The serine
protease Human Neutrophil Elastase (HNE) is a released enzyme with both direct and
indirect roles in bacterial killing by neutrophils [4,5]. However, HNE is also a causal factor
in the progression of emphysema and chronic obstructive pulmonary disease (COPD) [6,7]
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due to the enzyme’s propensity to propagate cyclic inflammation, recruit neutrophils, and
proteolytically destroy elastic lung tissue [8,9].
The degradation of inhibitors of other proteases makes HNE a uniquely destructive
enzyme [10]. When HNE is dysregulated, the resulting protease-antiprotease imbalance
initiates a proteolytic cascade that causes the characteristic pathologies observed in chronic
respiratory diseases and other chronic conditions. To ameliorate the hazards of unrestrained
HNE activity, the enzyme is targeted by reversible inhibitors, including the secretory
leukoprotease inhibitor (SLPI) [11], elafin [12], and the irreversible serpin inhibitor alpha 1
anti-trypsin (A1AT), which predominately controls HNE activity in the lung. However,
the potency of A1AT inhibition is entirely abrogated under oxidative conditions, such as
those induced by a neutrophil response to infection, due to the oxidation of a methionine
residue in the P1 position (Schechter–Berger nomenclature [13]) of its protease binding
surface [14,15]. Although not completely abolished, the potencies of SLPI and elafin are
diminished under oxidative conditions, due to the similar presence of methionine residues
in their protease binding loops [16,17]. Oxidation of inhibitor methionine residues may
be induced by oxidative stressors, such as cigarette smoke [18] or the respiratory burst
of neutrophils [19], potentiating runaway proteolysis. Since these endogenous inhibitors
bind to HNE in a substrate-like manner, the effects of methionine residue oxidation within
peptide substrates might be expected to be similar to the inhibitors. However, the oxidation
of P3 methionine residues in peptide substrates appears to enhance the HNE catalysed
cleavage rates of those substrates [20] and suggests a strong positional dependence.
Seminal to this work, Kasperkiewicz et al. [20] screened a combinatorial library of
unnatural (not genomically encoded) and natural amino acids to identify and develop an
activity-based probe capable of distinguishing between HNE and the closely related protease neutrophil proteinase 3 (PR3). This library screen and analyses showed an unexpected
HNE selectivity for an oxidised methionine residue at the P3 position of peptide substrates.
Subsequent crystallography to characterise the interaction between the screen-selected
activity-based probe PK101 and the HNE binding surface revealed an essential hydrogen
bond between a sulfonyl oxygen of the oxidised methionine residue and the backbone
amide of a unique Gly-Gly motif in the HNE S3 pocket [21]. Based on the interaction
between PK101 and HNE, the authors posited that HNE adapted to incorporate the GlyGly motif to proteolytically cleave substrates containing oxidised P3 methionine residues.
This notion is consistent with the observation of sulfone moieties in inhibitor drugs targeting HNE, including Sivelestat [22] and the Bayer inhibitor, BAY 85-8501 [23]. Thus,
HNE activity enhancement by methionine oxidation at the P3 position of HNE substrates
may hold special biological significance in vivo. However, PK101 and the optimal HNE
peptide substrates selected from the combinatorial library contain unnatural amino acid
residues [20], and the inhibitor drugs targeting HNE are small non-proteinaceous synthetic
molecules [22,23]. Although the data strongly suggest that a P3 methionine sulfone residue
in HNE substrates has biological relevance, a link has yet to be directly established. To better evaluate the biological relevance of HNE enhancement by the oxidised P3 methionine
residue in peptide substrates, and to further clarify the reported HNE substrate interactions,
we finely mapped HNE active site interactions using peptide substrates and inhibitors
comprised of naturally occurring (genomically encoded) amino acids that contain a P3 methionine residue in the three available oxidation states: methionine, methionine sulfoxide
and methionine sulfone.
2. Results
2.1. HNE Strongly Preferred Oxidised Methionine in Position P3 for Tetrapeptide pNA Substrates
and Additional Positional Effects
A focused sparse matrix library of tetrapeptides terminating in a para-nitroanilide
(pNA) reporter group was assembled to probe the substrate selectivity of HNE. The
library was constructed non-combinatorially as previously described [24], and the library
design was guided by previous HNE selectivity studies [20,25–27]. HNE catalytic rates
(mOD/min) were determined for each substrate, and the combined data are presented as
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a heat map in Figure 1A. Overall, selectivity for these individually synthesised peptides
roughly follows the HNE consensus cleavage sequence found in the MEROPS database [28]
shown in Figure 1B. These data confirm a strong selectivity for methionine sulfone residues
at position P3, as peptide substrates that included a methionine sulfone residue at position
P3 exhibited 19 of the 20 highest observed rates. This selectivity was position dependent, as
peptides containing methionine sulfone in the P2 position made universally poor substrates.
Interestingly, though unrelated to methionine oxidation, peptides containing glycine in the
P2 position also made universally poor substrates.

Figure 1. HNE substrate selectivity (A) heat map representation of tetra-peptide-pNA sparse matrix
library screened for activity in HNE kinetic assays. Bright green cells represent peptides that
showed high rates of HNE proteolysis, black cells represent peptides that showed no detectable
HNE proteolysis. Each square represents the average rate from three replicate experiments of
triplicate measurements. Final assay concentrations were 300 µM peptide-pNA and 1 µg/mL HNE.
(B) HNE consensus sequence derived from the MEROPS database showing amino acid frequency
distribution between positions P4 and P40 . Amino acids are coloured according to sidechain chemistry:
black = non-polar; green = polar; red = negatively charged and blue = positively charged.
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2.2. Positional Effects and the Effect of N-Terminal Acetylation
To better understand the interactions of the peptide substrates with HNE, five substrates among those exhibiting the highest catalytic rates were chosen for synthesis and
further analysis, along with two substrates showing intermediate and low catalytic rates.
The standard substrate MeOSuc-AAPV-pNA was also synthesised to provide a benchmark
against other studies. P1 alanine residues showed the highest catalytic rates (kcat ), but P1
valine residues showed the strongest substrate affinity. Acetylated forms of the P4 arginine
substrates were synthesised to assess the effect of a charged N-terminus. Acetylation had
little effect on kcat , but reduced a given substrate’s KM by approximately one-half (Figure 2
and Table 1). The KM for MeOSuc-AAPV-pNA was found to be 0.152 mM compared to a
previously published value of 0.14 mM [29].

Figure 2. Substrate concentration versus velocity plot of candidate pNA substrates containing a P1
valine residue (A), or a P1 alanine residue (B), assayed against 3 nM active HNE. Data series were
split between two figures due to the generally reduced maximum velocity of P1 valine substrates.
Data points represent the average rate observed from three replicate experiments of triplicate measurements. Concentration ranges of YM(O2 )AV-pNA and AM(O2 )AV-pNA were reduced due to
limiting solubility of these peptides. Error bars show SEM. Where not visible, error bars are smaller
than the pictured data point.
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Table 1. Kinetic constants calculated for candidate HNE pNA substrates. Substrates in each section are sorted by descending
kcat values. KM values are listed ± SEM.

High Rate
Intermediate Rate
Low Rate
Acetylated
Reference

Substrate

kcat (sec−1 )

KM (µM)

kcat /KM (M−1 sec−1 )

RM(O2 )PA-pNA
RM(O2 )AA-pNA
RM(O2 )AV-pNA
AM(O2 )AV-pNA
YM(O2 )AV-pNA
YEAV-pNA
REPA-pNA
Ac-RM(O2 )AA-pNA
Ac-RM(O2 )PA-pNA
Ac-REPA-pNA
Ac-RM(O2 )AV-pNA
MeOSuc-AAPV-pNA

13.72
11.60
3.70
2.16
3.42
2.24
4.22
13.50
13.14
3.82
3.37
2.90

765.1 ± 51.2
641.5 ± 51.8
107.7 ± 5.2
43.7 ± 5.7
96.8 ± 11.0
280.0 ± 28.6
2993 ± 1687
239.5 ± 20.4
417.7 ± 39.5
1113 ± 360.9
45.8 ± 2.3
152.9 ± 17.6

1.79 × 104
1.81 × 104
3.43 × 104
4.95 × 104
3.53 × 104
7.99 × 103
1.41 × 103
5.64 × 104
3.15 × 104
3.44 × 103
7.36 × 104
1.89 × 104

2.3. A Peptide Aldehyde Inhibitor of HNE as a Probe of HNE Substrate Interactions
Given the strong positional effects apparent for HNE, peptide aldehydes were used as
reversible transition state analogue inhibitors to further investigate the role of the peptide
sequence in HNE interactions. Since these inhibitors bind at serine protease active sites
similarly to their cognate substrates, peptide aldehyde inhibition is an appropriate proxy
for quantitating peptide/protease interactions. The most efficient HNE peptide substrate,
Ac-RM(O2 )AV-pNA, was synthesised as its peptide aldehyde equivalent, Ac-RM(O2 )AV-H,
and characterised in an inhibition assay. The inhibition constant (Ki ) for the Ac-RM(O2 )AVH inhibition of HNE proteolysis was determined to be 147 nM (Table 2).
Table 2. Comparison of the HNE peptide aldehyde inhibitor Ac-RMAV-H with derivatives containing
P3 methionine residues in sulfoxide and sulfone forms.

Ac-RMAV-H
Ac-RM(O)AV-H
Ac-RM(O2 )AV-H

Ki (nM)

Relative Potency

7266
5547
147

1
1.3
49.4

2.4. Peptide Aldehyde Inhibitors Show Differential Potency Dependent on P3 Methionine
Oxidation Status
The incorporation of pNA as a reporter group necessitated oxidation of the peptide
substrates during synthesis. Thus, synthesis of pNA substrates containing non-oxidised
methionine residues was not feasible. However, peptide aldehydes can be synthesised
to incorporate methionine residues in each of the available methionine oxidation states.
These inhibitors can effectively assess the interactions of methionine, methionine sulfoxide
and methionine sulfone with HNE using catalytic inhibition as a readout. The sulfone
derivative Ac-RM(O2 )AV-H exhibited a 49.4-fold inhibition enhancement relative to the
non-oxidised Ac-RMAV-H. By contrast, the sulfoxide derivative Ac-RM(O)AV-H enhanced
inhibition by only 1.3-fold compared to Ac-RMAV-H (Figure 3 and Table 2).
2.5. Molecular Modelling Suggests a Role for a Discrete Solvent Interaction in Binding Selectivity
between Methionine Residue Oxidative Forms
To investigate the role performed by methionine oxidation in HNE/peptide interactions, molecular dynamic simulations for each methionine residue oxidation state of the
aldehyde inhibitor with HNE in the presence of an explicit solvent was obtained. Predicted
hydrogen bonding interactions and sidechain dispositions for each of the inhibitors are
shown in Figure 4. The model predicts that the side chain of the P3 methionine and P3 methionine sulfoxide residues will deflect away from the active site, whilst the P3 methionine
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sulfone residue side chain will insert into the shallow HNE S3 pocket aided by a partial
occupancy (20%) hydrogen bond between the second sulfonyl oxygen and the main chain
of Gly193. Hydrogen bond interactions are predicted between discrete water molecules
and either the sulfinyl oxygen of the methionine sulfoxide residue or one of the sulfonyl
oxygens of the methionine sulfone residue.

Figure 3. Dose-response plot of Ac-RMAV-H peptide aldehyde inhibitor variants containing differing
oxidation states of the P3 methionine residue. All assays contained 10 nM active HNE and 100 nM AcRM(O2 )AA-pNA substrate. Data are reported as percent activity remaining compared to uninhibited
controls, and data points represent the mean observed from three replicate experiments of triplicate
measurements. Error bars show SEM. Where not visible, error bars are smaller than the pictured
data point.

Figure 4. HNE in complex with peptide aldehyde inhibitors (A) Ac-RMAV-H, (B) Ac-RM(O)AVH, (C) Ac-RM(O2 )AV-H, and (D) overlayed. Each complex used the final snapshot from a 10 ns
simulation and was energy minimised prior to alignment of the backbone atoms. Each peptide is
represented by a ribbon backbone structure and key P3 methionine sidechain that illustrates their
modified binding pattern to HNE. Measurement of the distance between carbonyl atoms for the three
variants revealed a 1.52 Å disparity between methionine sulfone versus native methionine, and only
a 0.18 Å displacement between methionine sulfoxide and native methionine. This shift in conjunction
with the hydrogen bond seen between Gly218/219 would suggest that the movement of the peptide
backbone is caused by the hydrogen bond network of this loop.
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3. Discussion
3.1. Tetrapeptide Substrates Composed of Naturally Occurring Amino Acids Containing a P3
Methionine Sulfone Residue Enhance HNE Catalysis
The data reported here are consistent with a significant biological role for the previously reported [20] HNE enhancement by substrates containing a P3 methionine sulfone
residue. The highest HNE catalysed rates were observed for peptide substrates from our
library containing a P3 methionine sulfone residue. Further, a peptide aldehyde based
on a preferred peptide substrate sequence inhibited HNE with a Ki of 147 nM. As our
library contained only peptide substrates comprised of genomically encoded amino acids,
this suggests that HNE can specifically target naturally occurring substrates in vivo under
neutrophil-induced oxidative conditions. The observations that either methionine sulfone
residues in the P2 position or glycine in the P2 position yielded universally poor HNE
substrates, confirm a positional dependence dictated by the bonding surface.
3.2. HNE Substrate Selectivity and Positional Effects
Oxidation of methionine is a two-step process, in which the methionine residue is first
oxidised to the sulfoxide and then irreversibly oxidised to the sulfone [30]. Taken together,
the data reported here for the peptide substrates and the peptide aldehyde-based inhibitors
suggest that HNE discriminates between the sulfoxide and sulfone forms of oxidised
P3 methionine residue in the S3 pocket. The observation that the sulfone derivative AcRM(O2 )AV-H exhibited a 49.4-fold inhibition enhancement relative to the non-oxidised
Ac-RMAV-H suggests that the inhibition enhancement largely stemmed from increased
inhibitor binding. Thus, the likely effect of P3 methionine oxidation to the sulfone in HNE
substrates is to lower the Km .
A pronounced HNE preference for peptide substrates with valine at P1 was previously reported [20]. In our hands, the P1 alanine substrates among the five “high rate”
substrates chosen from our screen exhibited greater HNE catalytic turnover (kcat ) than the
P1 valine substrates by at least a factor of 3.5 (Table 1). However, when catalytic efficiency
(kcat /Km ) was analysed, no clear distinction between P1 alanine and P1 valine emerged.
With respect to P1 valine efficiency, strong substrate affinity offset weak catalysis in the
binding site, while with respect to P1 alanine efficiency, poor binding affinity was offset
by strong catalysis. The difference in P1 preference observed between library screens is
likely an artefact of the different reaction conditions used. Library screening results using
protocols based on catalytic rate as a readout differ depending on whether the protocol
was performed under enzyme saturating conditions. Under sub-saturating conditions, the
rate expression is v = kcat
Km [E][S]. Sub-saturated screening favours substrates with smaller
Km s (i.e., higher binding affinity) to compensate when [S] is very small. Under saturating
conditions, the rate expression simplifies to v = kcat[E], and screening favours substrates
with faster rates of catalysis in the enzyme binding site (kcat ), without regard to substrate
binding affinity (Km ). The previous combinatorial library [20] was constructed of pools of
many thousands of peptides, each in very low concentration, and each individual substrate
concentration was likely to be far below its respective Km . Thus, screening selection was
likely dominated by substrate binding affinity (Km ). By contrast, our sparse matrix library
consisted of only 144 total substrates, each substrate present at a concentration of 300 µM.
Excluding REPA-pNA, which was chosen as an example of a poor HNE substrate, only
two of the remaining six chosen pNA substrates listed in Table 1 had Km values greater
than 300 µM. Those two, RM(O2)PA-pNA and RM(O2)AA-pNA, had Km values that were
only approximately twice the substrate concentration of the screen, well-within an order
of magnitude. Therefore, our library screen selection was primarily dominated by kcat .
This might explain why the combinatorial library screening would select strong-binding
substrates incorporating unnatural amino acid residues over weaker-binding substrates
composed only of natural amino acid residues, which might have greater biological relevance. This sub-saturating characteristic might be useful for strong-binding substrate
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applications, such as identifying competitive inhibitor candidates from a combinatorial
library screen.
Finally, unlike the tetrapeptide substrates used in the sparse matrix library, biologically
relevant substrate cleavage sites are embedded in the interior of longer protein chains,
and therefore rarely near the positively charged N-terminus. To mimic this condition,
we acetylated the best tetrapeptide substrates chosen in our library screen to produce
uncharged N-termini. N-terminal acetylation increased substrate binding affinity to HNE
without appreciably affecting the catalysis mechanism in the active site.
3.3. The Role of Bulk Water in the HNE Mechanism of Discrimination against P3
Methionine Sulfoxide
The crystal structure of the methionine sulfonyl-containing inhibitor PK-101 [21] identified a hydrogen bond between the oxidised methionine residue present in PK-101 and
the main chain amide at Gly219 in the S3 pocket of HNE. The associated diglycine motif is
unique to HNE among all human serine proteases and is a hallmark of an adaptation to
oxidised substrates. Our kinetic data and molecular modelling predictions are consistent
with an important role for P3 methionine sulfone substrates in HNE proteolytic activity
enhancement via a mechanism similar to that described for PK-101 [21]. The P3 methionine sulfoxide residue, which is a far more common oxidative product in vivo than the
sulfone, surprisingly failed to enhance interactions with HNE despite containing a sulfinyl
oxygen similarly positioned to a hydrogen bond in the HNE S3 pocket. Indeed, molecular
dynamic simulations predict that the methionine sulfoxide sidechain will deflect away
from the S3 pocket and be solvent exposed. Closer examination of the molecular dynamics
trajectories revealed solvent hydrogen bonding with the sulfinyl and sulfone oxygens of
the P3 methionine sulfoxide residue and P3 methionine sulfone residue. However, as
secondary amides are significantly weaker hydrogen bond donors than water [31], the
backbone amide hydrogen bond donor at Gly219 is thermodynamically unable to compete
with the solvent water molecule for the single sulfinyl oxygen hydrogen bond acceptor on
the methionine sulfoxide residue. In contrast, the methionine sulfone residue contains two
sulfonyl oxygens, and is predicted to simultaneously form hydrogen bonds with both the
solvent water molecule and the main chain amide at Gly219 (see Figure S1 for trajectories).
As our aldehyde HNE inhibitors suggest that the P3 methionine sulfone residue increases
binding affinity, decreasing the Km would explain why a P3 methionine sulfone enhances
HNE catalysis while a P3 methionine sulfoxide does not.
3.4. Biological and Clinical Implications of Selection for P3 Methionine Sulfone
Whilst the mechanism of selection between the two forms of oxidised methionine
is clear, the biological justification for this discrimination by HNE seems more obscure.
Although unusual, oxidised methionine residues have been observed in biological samples [32]. Why would it be important to cleave one form of oxidised methionine but not
the other? The biological significance may lie in the way that methionine sulfoxide and
methionine sulfone residues are repaired by pathogens. The sulfoxide moiety is a substrate
for repair enzymes that are vital for bacterial resistance to neutrophil killing. These enzymes, methionine sulfoxide reductase A and B, convert partially oxidised methionine back
to the reduced form. Significantly, methionine sulfoxide reductase knockout bacteria are
sensitized to the cell killing effects of hydrogen peroxide [33,34]. Hence, bacteria can readily
repair the oxidative “cut here” tags affixed by neutrophil activity so long as oxidation does
not progress to the sulfone state.
The potential clinical consequences of HNE’s methionine sulfone selectivity are twofold. Firstly, the neutrophil oxidative burst has the capacity to target HNE activity towards
pathogen-derived proteins that were oxidised, and secondly, host proteins that are collaterally exposed to oxidation might also become preferred substrates. Accelerated cleavage
of pathogen proteins, especially virulence factors, would be advantageous, as it would
represent a secondary targeted attack by HNE on the invading pathogens. Examples of
HNE pathogen substrates include outer membrane protein A (OmpA) in E. coli, where
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its degradation is lethal [35], and the cleavage of flagellin from Pseudomonas aeruginosa,
which abrogates its biological activity [36]. Both of these targets have consensus cleavage
sequences defined in the MEROPS database for HNE that contain oxidisable methionine
residues (Flagellin E163 MSA, OmpA G141 MLS) [28]. In contrast to the beneficial effects of
accelerated pathogen degradation, oxidation of host proteins and their accelerated cleavage
by HNE would lead to increased rates of collateral tissue damage. This in turn would
have the potential to set up a chronic cycle of oxidation followed by tissue damage and
further recruitment of neutrophils. Such collateral damage may also be occurring in acute
conditions such as the lung damage caused by COVID-19 infection.
3.5. Conclusions
In the pursuit of understanding how methionine oxidation modulates substrate and inhibitor interactions with human neutrophil elastase, there is one critical question that must
be asked: is the modification of P3 methionine to methionine sulfone able to be induced by
natural mechanisms, or is it only applicable to synthetic molecules and unnatural amino
acid residues? The Gly-Gly motif that is unique to HNE suggests an evolutionary pressure
to conserve the observed methionine sulfone selectivity in HNE, and a mouse model of
radiation-induced oxidative stress [37] shows that it is certainly possible for methionine
residues to oxidise to the sulfone in vivo. However, methionine oxidation to the sulfone
is infrequent, and depends on a combination of strong oxidative stress and the intrinsic
vulnerability of only select methionine residues. Using tetrapeptide substrates composed
entirely of naturally occurring amino acids, we showed that P3 methionine residue oxidation to the sulfone may be biologically relevant, but this remains to be demonstrated in
biologically relevant protein molecules.
We showed that oxidation of methionine to the sulfone in HNE-interacting peptides
greatly increases their affinity for the enzyme. This and the demonstrated ability of
endogenous oxidation systems to inactivate HNE’s chief inhibitor, may justify research that
investigates the utility of antioxidant treatment in acute and non-acute immune conditions
such as COVID-related respiratory distress and COPD.
4. Materials and Methods
4.1. Peptide Synthesis
To produce the 144 tetra-peptide pNA substrates we employed standard Fmoc solid
phase peptide synthesis (SPPS) protocols [38]. The scale of the library synthesis was
such that 0.05 mmol of each final peptide was to be produced, a total of 7.20 mmol. Into
large Bio-Rad Poly-Prep columns, 4.8 g of 2-chlorotrityl resin (1.52 mmol available Cl/g)
was derivatised with an 8x molar equivalent of both para-phenylenediamine (pPD) and
diisopropylethylamine (DIPEA) and solubilised in dimethylformamide (DMF) to bring
final the DIPEA concentration to 10%. Columns were covered with aluminium foil to
exclude light and left slowly rotating for 16 h at RT. After pPD derivatisation, the resin was
drained, then washed with DMF three times to remove all excess reactants. Unoccupied
2-chorotrityl groups were capped by treatment with a column volume of 10% methanol,
slowly rotated for 30 min at RT, drained and washed with DMF three times. After pPD
derivatization chain elongation followed conventional practice with 50% piperidine in DMF
as deprotectant and coupling effected by activating Fmoc amino acids with 1.1 Meq of 2-(6Chloro-1H-benzotriazole-1-yl)-1,1,3,3-tetramethylaminium hexafluorophosphate (HCTU).
The resin was washed three times with vacuum aspiration between each step. Both coupling
and deprotection were agitated by sparging with dried nitrogen. Once chain elongation
was completed, peptides were cleaved from the 2-chlorotrityl resin by treatment with 5%
Trifluoroacetic acid (TFA) in DCM keeping side chain protection intact and harvested by
trituration in 10 volumes of ice-cold diethyl ether. The para-aminoanilide group of the
harvested peptides was oxidised by treatment with 4 Meq of Oxone. Briefly, peptides were
re-solubilised with acetonitrile:water (1:1 v/v) containing Oxone and left mixing overnight
at RT protected from light. Ethyl acetate was used to extract the oxidised protected peptides
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from the aqueous oxidation solution and was subsequently removed by evaporation under
a stream of dried compressed air. RMAV-H peptide aldehydes were synthesised using an
oxazolidine protection approach on Novabiochem H-Thr-Gly-NovaSyn TG resin (Merck).
This resin was purchased preloaded with Fmoc-valinal (0.17 mmol/g equivalent) at a
density of 0.5 mM/g. Chain elongation was achieved as with the pNA substrates. Prior to
oxazolidine cleavage, the amino acid side chains required deprotection by treatment with
anhydrous TFA for 30 min and washing with 3 x DMF followed by 3 x DCM washes. Once
completed, the peptide was released from the synthesis resin using a mixture of 10% acetic
acid, 5% water, 63% DCM and 21% methanol prior to trituration as for the pNA substrates.
RM(O)AV-H was synthesised using a building block approach incorporating Fmoc-Met(O)
at P3 and RM(O2 )AV-H was formed by subjecting RMAV-H to on-resin oxidation with
6 Meq of Oxone in 50% acetonitrile at the end of the chain elongation. Substrates for
kinetic analysis and the aldehyde inhibitors were both subject to solid phase extraction on
Grace C18 SPE columns particle size: 50 µm; column phase: reversed; bed weight: 900 mg,
before purification on a Kinetex 5 µm XB-C18 100 Å RP-HPLC column (Phenomenex)
with peptides eluted with a gradient of 10–100% acetonitrile in ultrapure water with
0.1% TFA as a modifier. Peptide elution was monitored at 214 nm. Post purification,
peptide containing fractions were analysed by LC-MS on a Sciex QTrap 4500 Q1 scan over
50–1500 m/z. Mobile phase used was 40% acetonitrile containing 0.1% formic acid as a
modifier. Validated peptides were subject to lyophilization, weighed and either redissolved
in 30% isopropanol at a concentration of 6 mM and stored frozen at −20 ◦ C, or for long
term storage peptides were maintained as dried powders at −80 ◦ C.
4.2. Enzyme Kinetic Assays
For substrate library kinetic assay screen, reactions were initiated by addition of
HNE purified from purulent human sputum (Elastin Products Company, Owensville, MO,
USA) to triplicate microplate wells containing each substrate, and the rate of reaction
determined spectrophotometrically at 405 nm. Final concentrations were 300 µM substrates
and 1 µg/mL HNE in 250 µL assay buffer (100 mM Tris pH 8, 50 mM NaCl, 10% DMF,
0.05% Triton X-100). For in-depth assays of candidate substrates and inhibitors, the active
site concentration of HNE was first determined by titration with A1AT. Briefly, 250 nM
A1AT was serially diluted in a 96-well microplate to provide a final assay volume of
250 µL. A total of 2.5 µL of HNE stock solution (100 µg/mL) was added to each well
and complex formation was allowed to proceed over a period of 20 min at RT. Assays
were initiated by addition of Ac-RM(O2 )PA-pNA substrate, monitoring the evolution
of free para-nitroanilide at 405 nm for 90 s again at RT. Kinetic assays of synthesized
pNA substrates were carried out similarly omitting the A1AT and serially diluting the
substrates, KM and Vmax values were determined by GraphPad Prism 5.01 (La Jolla, CA,
USA) Michaelis–Menten non-linear regression. Assays with peptide aldehyde inhibitors
were carried out as with the active site titration. Inhibition constants were calculated in
GraphPad Prism by non-linear regression using the Morrison equation for tight-binding
inhibitors [39].
4.3. Molecular Modelling
The crystal structure 4WVP determined by Lechtenberg et al. [21] was used as the
basis for predicting inhibitor/HNE interactions. Initially, the bound probe in 4WVP
was converted to the natural amino acid containing peptides RMAV-H, RM(O)AV-H and
RM(O2 )AV-H within the YASARA suite of programs. Molecular simulation on each of the
resulting complexes was carried out with VMD 1.9.2 [40] and NAMD 2.9 [41] packages on
a GPU cluster built in-house. HNE/Inhibitor complexes were solvated in TIP3P water, in a
simulation cell neutralised with 0.1 M Na+ and Cl− counter ions and parameterised with
the CHARMM27 force field [42]. Each of the three complexes were subject to molecular
dynamics consisting of a three-step relaxation followed by three independent production
runs of 10 ns simulation time [43]. In the first step, the integration time step was set to 1 fs
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and harmonic restraints of 2 kcal·mol−1 ·Å−2 was applied on all heavy atoms. A 1000-step
conjugate gradient minimisation was performed followed by 500 ps of molecular dynamics
simulation. In the second step, and restraints retained on protein Cα atoms and the system
was equilibrated for 1 ns with 2 fs time step. In the third step, the system was simulated
for 1 ns with all restraints removed. After equilibration, three independent production
runs (20 ns each run) were performed in the NPT ensemble. In all simulations, Langevin
dynamics were used to maintain constant temperature (298 K) with a damping coefficient
of 5 ps−1 . Pressure within the simulation cell was regulated with a Langevin piston barostat
with an oscillation period of 100 fs maintaining a constant 1 atm. Long-range electrostatics
were treated by the Particle-Mash-Ewald (PME) method with a 9 Å cut-off. Snapshots were
saved every 1 ps. The analysis of simulation trajectories was performed on VMD 1.9.2 [40].
Hydrogen bond length and angle cut-offs were set to 3.3 Å and 40◦ .
Supplementary Materials: Figure S1. Trajectories for molecular dynamic simulation of HNE in
complex with RMAV-H peptide aldehyde and its oxidized variants. Figure S2. SDS PAGE analysis of
HNE supplied by Elastin Products Company. Table S1. Calculated and observed masses of candidate
peptide-pNA substrates and peptide aldehyde inhibitors. All masses are listed in Daltons.
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